These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37004423)

  • 41. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Mustansar T; Mirza T; Hussain M
    Biotech Histochem; 2023 Nov; 98(6):382-390. PubMed ID: 37013448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TP53 positivity combined with high fibrinogen expression defines a subtype of oral squamous cell carcinoma with an unfavorable prognosis.
    Inoue A; Matsumoto T; Ito Y; Saegusa M; Takahashi H
    Hum Pathol; 2022 Dec; 130():25-35. PubMed ID: 36441045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans.
    Rebaudi F; De Rosa A; Greppi M; Pistilli R; Pucci R; Govoni FA; Iacoviello P; Broccolo F; Tomasello G; Pesce S; Laganà F; Bianchi B; Di Gaudio F; Rebaudi A; Marcenaro E
    Front Immunol; 2023; 14():1216107. PubMed ID: 37483588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization.
    Padin-Iruegas E; Chamorro-Petronacci CM; Sines-Cajade I; Lorenzo-Pouso AI; Blanco-Carrión A; Pérez-Jardón A; Gándara-Vila P; Pérez-Sayans M
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888599
    [No Abstract]   [Full Text] [Related]  

  • 46. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
    Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
    Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relevance and actionable mutational spectrum in oral squamous cell carcinoma.
    Jayaprakash C; Varghese VK; Jayaram P; Chakrabarty S; Kudva A; Ray S; Satyamoorthy K
    J Oral Pathol Med; 2020 May; 49(5):427-434. PubMed ID: 31845386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy.
    Sambath J; Noronha V; Manda SS; Mishra R; Chandrani P; Patil V; Menon N; Chougule A; Ramachandran V; Limaye S; Kuriakose MA; Banavali SD; Kumar P; Prabhash K
    Gene; 2024 Jan; 893():147952. PubMed ID: 37918550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
    Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
    Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
    Zhao G; Li CX; Guo C; Zhu H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
    Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
    BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulation of Synuclein-
    Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
    Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
    Yap T; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; Seers C; McCullough M
    Cancer Prev Res (Phila); 2018 Aug; 11(8):491-502. PubMed ID: 29764807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic association between PIK3CA gene and oral squamous cell carcinoma: a case control study conducted in Chongqing, China.
    Wan X; Li X; Yang J; Lv W; Wang Q; Chen Y; Li Y
    Int J Clin Exp Pathol; 2015; 8(10):13360-6. PubMed ID: 26722541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation.
    Tinhofer I; Stenzinger A; Eder T; Konschak R; Niehr F; Endris V; Distel L; Hautmann MG; Mandic R; Stromberger C; Weichert W; Budach V
    Ann Oncol; 2016 Dec; 27(12):2262-2268. PubMed ID: 27681865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.